Bloodline Breakthroughs: innovations & inspiration | Polycythemia vera (PV)

In this episode of Bloodline Breakthroughs, we take a closer look at polycythemia vera (PV) - what it is, how it develops, and how it is treated - with insights from Dr. Brandi Reeves of the University of North Carolina. Dr. Reeves explains how PV belongs to a group of blood cancers called myeloproliferative neoplasms, or MPNs. and walks through how mutations like JAK2 drive the disease. She also discusses how PV is diagnosed, common symptoms patients may not recognize, and current treatment approaches, as well as promising research that may help shape the future of care. Mentioned in the episode: Polycythemia vera (myeloproliferative neoplasms): https://www.bloodcancerunited.org/MPN Advocacy and Public Policy: https://www.bloodcancerunited.org/adv... Clinical Trial Support Center: https://www.bloodcancerunited.org/nav... This episode supported by: PharmaEssentia USA Corporation and Takeda Oncology View more episodes of Bloodline Breakthroughs: innovations and inspiration at https://bloodcancerunited.org/resourc...